Posts by admin:

Champion REIT Hosts ESG-Themed Event for a Third Year, Redefining Value and Sustainable Future of Commercial Properties Through Innovation

HONG KONG, July 31, 2025 – (ACN Newswire via SeaPRwire.com) – Champion Real Estate Investment Trust (“Champion REIT” or the “Trust”) (Stock Code: 2778), owner of Three Garden Road and Langham Place, is pleased to announce the grand opening of its third annual ESG-themed event, the “ESG Gala”, which is held between 29 July and […]

Scipio Capital Advisors Capital Raise puts Alternative Asset Yield Within Reach of Accredited Investors

MIAMI, FL, July 31, 2025 – (ACN Newswire via SeaPRwire.com) – “Our mission has always been clear: unlock high-yield investment opportunities while empowering underserved markets,” said Will Panter, Managing Partner at Scipio Capital Advisors. “We’re proud to consistently deliver stable, reliable income streams-both to individual investors and to institutional partners who trust our strategy.” Scipio Capital […]

UPCX Name Marketplace: Empowering Blockchain Addresses with Value

Blockchain Technology is Reshaping Digital Finance and Commerce, but the Cumbersome Nature of On-Chain Addresses Remains a Key Barrier to User Adoption and Innovation. To Make Blockchain Accounts “Readable, Usable, and Tradable,” Developers Worldwide Are Continuously Exploring Innovations in Naming Services and Digital Identity Systems. Now, UPCX is about to launch its mainchain-native UPCX Name […]

New Report Reveals Key Considerations For Successful Distribution Onboarding

Nashville, TN, July 30, 2025 – (ACN Newswire via SeaPRwire.com) – The Global Technology Distribution Council (GTDC) released its collaborative research report titled “The Distribution Onramp: A Quick-Start Guide for Established and Emerging Technology Vendors” during the GTIA ChannelCon event this week. The engaging new study provides valuable best practices for initiating and developing strong and mutually beneficial […]

HKTDC welcomes the ‘Report on Hong Kong’s Business Environment’ and continues to actively promote Hong Kong’s advantages

HONG KONG, July 30, 2025 – (ACN Newswire via SeaPRwire.com) – The Hong Kong Trade Development Council (HKTDC) welcomes the release of the “Report on Hong Kong’s Business Environment: Unique Strengths under ‘One Country, Two Systems’” by the Hong Kong Special Administrative Region (HKSAR) today. Prof Frederick Ma, Chairman of the HKTDC, said, “This report […]

Hong Kong Shopping Festival Returns in August with Bigger and Better 2nd Edition

– The HKTDC returns with the second Hong Kong Shopping Festival in August, building on the initiatives in the 2024 Policy Address to help local SMEs expand into the Mainland China market through e-commerce channels– The Hong Kong Shopping Festival is the flagship event of the E-commerce Express, and has received an enthusiastic response, attracting nearly 260 brands presented by […]

Ongoing Share Buybacks Demonstrate Confidence, Shoucheng Holdings Boosts Market Expectations with Concrete Action

HONG KONG, July 30, 2025 – (ACN Newswire via SeaPRwire.com) – Shoucheng Holdings Limited (0697.HK) recently announced via the Hong Kong Stock Exchange that it repurchased 17.65 million shares through on-market transactions on July 29, 2025, with a total consideration of HK$32.301 million. The repurchase price ranged from HK$1.80 to HK$1.86 per share. This marks […]

Naoris Protocol Announces Upcoming TGE for $NAORIS

Naoris is Spearheading the First Decentralized Post-Quantum Infrastructure for Web2, Web3 & Web 4 WELLINGTON, FL, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – Naoris Protocol, the first in production quantum-resistant blockchain and cybersecurity mesh architecture, has announced its upcoming TGE for July 31, 2025, marking a key milestone in the rollout of a new […]

Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

HAYWARD, CALIFORNIA, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog’s acquisition of Anaerobe […]

GTJAI Achieved ‘Carbon Neutrality’ at Operational Level for the Third Consecutive Year

HONG KONG, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – July 25, Guotai Junan International Holdings Limited (“GTJAI” or the “Company”, stock code: 1788.HK), a company of Guotai Haitong Group, is pleased to announce that while actively saving energy and reducing emissions,it has successfully offset its Scope 1 and Scope 2 carbon emissions totaling 609.29 […]

China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer’s Disease Accepted in China

SHENZHEN, CHINA, July 29, 2025 – (ACN Newswire) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) (“ZUNVEYL” or the “Product”) has been accepted by the National Medical Products Administration of China […]

Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains

HONG KONG, July 29, 2025 – (ACN Newswire via SeaPRwire.com) – On one front, Unitree is accelerating toward an IPO, aiming to become “China’s first publicly listed robotics company.” On the other, Booster Robotics has just secured a historic championship at the RoboCup World Cup. These two Chinese robotics leaders have captured industry and capital market […]

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

ANKARA, Turkey, July 28, 2025 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, announced positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class and novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the Alzheimer’s […]

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

ANKARA, Turkey, July 28, 2025 – (ACN Newswire via SeaPRwire.com) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, announced positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class and novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the Alzheimer’s […]